"cancer death" trang 11 - tải miễn phí từ tailieunhanh
Melanoma-specific mortality and competing mortality in patients with non-metastatic malignant melanoma: A population-based analysis

Melanoma-specific mortality and competing mortality in patients with non-metastatic malignant melanoma: A population-based analysis
11    69    1
PRIMA-1MET induces death in soft-tissue sarcomas cell independent of p53

PRIMA-1MET induces death in soft-tissue sarcomas cell independent of p53
8    36    1
Downregulation of programmed cell death 10 is associated with tumor cell proliferation, hyperangiogenesis and peritumoral edema in human glioblastoma

Downregulation of programmed cell death 10 is associated with tumor cell proliferation, hyperangiogenesis and peritumoral edema in human glioblastoma
11    59    1
Sorafenib inhibits intracellular signaling pathways and induces cell cycle arrest and cell death in thyroid carcinoma cells irrespective of histological origin or BRAF mutational status

Sorafenib inhibits intracellular signaling pathways and induces cell cycle arrest and cell death in thyroid carcinoma cells irrespective of histological origin or BRAF mutational status
13    35    1
Lack of treatment-related mortality definitions in clinical trials of children, adolescents and young adults with lymphomas, solid tumors and brain tumors: A systematic review

Lack of treatment-related mortality definitions in clinical trials of children, adolescents and young adults with lymphomas, solid tumors and brain tumors: A systematic review
5    36    1
Triptolide induces apoptotic cell death of human cholangiocarcinoma cells through inhibition of myeloid cell leukemia-1

Triptolide induces apoptotic cell death of human cholangiocarcinoma cells through inhibition of myeloid cell leukemia-1
10    36    1
PMA synergistically enhances apicularen A-induced cytotoxicity by disrupting microtubule networks in HeLa cells

PMA synergistically enhances apicularen A-induced cytotoxicity by disrupting microtubule networks in HeLa cells
9    41    1
Phenethyl isothiocyanate induces calcium mobilization and mitochondrial cell death pathway in cholangiocarcinoma KKU-M214 cells

Phenethyl isothiocyanate induces calcium mobilization and mitochondrial cell death pathway in cholangiocarcinoma KKU-M214 cells
12    30    1
Survivin selective inhibitor YM155 induce apoptosis in SK-NEP-1 Wilms tumor cells

Survivin selective inhibitor YM155 induce apoptosis in SK-NEP-1 Wilms tumor cells
13    61    1
Early discontinuation of PD-1 blockade upon achieving a complete or partial response in patients with advanced melanoma: The multicentre prospective Safe Stop trial

Early discontinuation of PD-1 blockade upon achieving a complete or partial response in patients with advanced melanoma: The multicentre prospective Safe Stop trial
9    42    1
Radotinib enhances cytarabine (Ara-C)- induced acute myeloid leukemia cell death

Radotinib enhances cytarabine (Ara-C)- induced acute myeloid leukemia cell death
15    43    1
Effcacy of immune checkpoint inhibitors in non-small cell lung cancer with uncommon histology: A propensity-score-matched analysis

Effcacy of immune checkpoint inhibitors in non-small cell lung cancer with uncommon histology: A propensity-score-matched analysis
9    63    1
Nanoparticle albumin-bound paclitaxel and PD-1 inhibitor (sintilimab) combination therapy for soft tissue sarcoma: A retrospective study

Nanoparticle albumin-bound paclitaxel and PD-1 inhibitor (sintilimab) combination therapy for soft tissue sarcoma: A retrospective study
9    55    3
Safety, activity, and pharmacokinetics of camrelizumab in advanced Asian melanoma patients: A phase I study

Safety, activity, and pharmacokinetics of camrelizumab in advanced Asian melanoma patients: A phase I study
10    26    1
Rituximab in combination with gemcitabine plus cisplatin in patients with recurrent and metastatic head and neck squamous cell carcinoma: A phase I trial

Rituximab in combination with gemcitabine plus cisplatin in patients with recurrent and metastatic head and neck squamous cell carcinoma: A phase I trial
10    21    2
Anti-tumor treatment and healthcare consumption near death in the era of novel treatment options for patients with melanoma brain metastases

Anti-tumor treatment and healthcare consumption near death in the era of novel treatment options for patients with melanoma brain metastases
11    21    1
Prognostic value and immune relevancy of a combined autophagy-, apoptosisand necrosis-related gene signature in glioblastoma

Prognostic value and immune relevancy of a combined autophagy-, apoptosisand necrosis-related gene signature in glioblastoma
21    13    1
Real-world efficiency of lenvatinib plus PD-1 blockades in advanced hepatocellular carcinoma: An exploration for expanded indications

Real-world efficiency of lenvatinib plus PD-1 blockades in advanced hepatocellular carcinoma: An exploration for expanded indications
8    19    1
Three-year weight change and risk of all-cause, cardiovascular, and cancer mortality among Iranian adults: Over a decade of follow-up in the Tehran Lipid and Glucose Study

Three-year weight change and risk of all-cause, cardiovascular, and cancer mortality among Iranian adults: Over a decade of follow-up in the Tehran Lipid and Glucose Study
11    11    1
Time trends in survival and causes of death in multiple myeloma: A population-based study from Germany

Time trends in survival and causes of death in multiple myeloma: A population-based study from Germany
10    2    1